Ginkgo Bioworks Holdings, Inc.
DNA
$9.34
-$0.56-5.66%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.18% | 72.24% | 45.18% | 49.20% | 81.38% |
| Total Depreciation and Amortization | -95.66% | -8.87% | 19.40% | 21.93% | -81.63% |
| Total Amortization of Deferred Charges | 5.26% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -37.22% | -75.39% | -43.86% | -52.24% | -83.93% |
| Change in Net Operating Assets | 114.05% | -486.28% | -3,806.73% | -94.82% | -5,272.11% |
| Cash from Operations | 69.46% | 52.30% | 42.28% | 26.62% | -40.72% |
| Capital Expenditure | 100.00% | 99.86% | -13.59% | -297.85% | -244.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -96.01% | 698.65% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,794.18% | -33,529.32% | -- | 133.89% | 364.15% |
| Cash from Investing | -613.88% | -138.02% | -1,540.66% | 71.97% | -201.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 88.00% | 51.00% | 29.59% | 36.16% | 39.21% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -33.96% | -- | -- | 100.00% | -546.34% |
| Cash from Financing | 2,237.20% | 56.64% | 75.50% | 67.88% | -47.62% |
| Foreign Exchange rate Adjustments | 365.71% | 1,262.50% | 147.13% | -171.57% | 82.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.35% | 6.66% | -144.54% | 46.88% | -47.47% |